交易 Marker Therapeutics, Inc. - MRKR CFD
加入收藏夹- 概括
- 历史数据
- 活动
- 收入报表
- 资产负债表
- 现金流
- 所有权
交易条件
| 价差 | - | ||||||||
|
多头隔夜费
Long position overnight fee
前往平台 | -0.025457% | ||||||||
|
空头隔夜费
Short position overnight fee
前往平台 | 0.003235% | ||||||||
| 隔夜费时间 | 21:00 (UTC) | ||||||||
| 最小交易量 | 1 | ||||||||
| 货币 | USD | ||||||||
| 保证金 | 20% | ||||||||
| 上市交易所 | United States of America | ||||||||
| 交易费 | 0% |
*Information provided by Capital.com
Marker Therapeutics Inc ESG Risk Ratings
High Medium Low Negligible
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | 平仓 | Change | Change (%) | 開倉 | High | Low |
|---|
Marker Therapeutics, Inc. Events
| 时间（协调世界时） (UTC) | 国家/地区 | 事件 |
|---|---|---|
| Tuesday, June 6, 2023 | ||
| 时间（协调世界时） (UTC) 13:00 | 国家/地区 US
| 事件 Marker Therapeutics Inc Annual Shareholders Meeting Marker Therapeutics Inc Annual Shareholders MeetingForecast -Previous - |
| Wednesday, August 9, 2023 | ||
| 时间（协调世界时） (UTC) 10:59 | 国家/地区 US
| 事件 Q2 2023 Marker Therapeutics Inc Earnings Release Q2 2023 Marker Therapeutics Inc Earnings ReleaseForecast -Previous - |
| Wednesday, November 8, 2023 | ||
| 时间（协调世界时） (UTC) 10:59 | 国家/地区 US
| 事件 Q3 2023 Marker Therapeutics Inc Earnings Release Q3 2023 Marker Therapeutics Inc Earnings ReleaseForecast -Previous - |
- 年度
- 每季度
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| 总收入 | 9.01354 | 1.24171 | 0.46679 | 0.21319 | 0.20599 |
| 总营业费用 | 39.1923 | 43.1263 | 29.3526 | 22.742 | 148.378 |
| 销售/一般/行政费用，总计 | 12.82 | 12.9248 | 10.4719 | 9.9772 | 24.3799 |
| 研究与开发 | 26.1393 | 27.7949 | 18.8808 | 12.7648 | 123.998 |
| 异常费用（收入） | 0.23297 | 2.40658 | 0 | ||
| 营业收入 | -30.1788 | -41.8846 | -28.8858 | -22.5288 | -148.172 |
| 利息收入（费用），非经营净值 | 0.24806 | 0.0057 | 0.17974 | 1.10084 | 0.21372 |
| 其他，净值 | |||||
| 税前净收入 | -29.9307 | -41.8789 | -28.7061 | -21.428 | -147.958 |
| 税后净收入 | -29.9307 | -41.8789 | -28.7061 | -21.428 | -147.958 |
| 未计算非常项目前的净收益 | -29.9307 | -41.8789 | -28.7061 | -21.428 | -147.958 |
| 净收入 | -29.9307 | -41.8789 | -28.7061 | -21.428 | -147.958 |
| 普通股股东可获收益 (不含非经常性项目) | -29.9307 | -41.8789 | -28.7061 | -21.428 | -147.958 |
| 普通股股东可获收益 (含非經常性項目) | -29.9307 | -41.8789 | -28.7061 | -21.428 | -147.958 |
| 摊薄净收入 | -29.9307 | -41.8789 | -28.7061 | -21.428 | -147.958 |
| 摊薄后加权平均股 | 8.351 | 7.65057 | 4.70399 | 4.55877 | 1.90919 |
| 扣除特别项目的每股摊薄盈利 | -3.58408 | -5.47396 | -6.1025 | -4.70038 | -77.4976 |
| 每股正常摊薄盈利 | -3.55619 | -5.15939 | -6.1025 | -4.70038 | -77.4976 |
| 收入 | 9.01354 | 1.24171 | 0.46679 | 0.21319 | 0.20599 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| 总收入 | 4.73434 | 3.30914 | 3.94957 | 0.79051 | 0.96432 |
| 总营业费用 | 9.78657 | 7.27497 | 10.9689 | 10.0705 | 10.8779 |
| 销售/一般/行政费用，总计 | 2.51582 | 1.89382 | 3.67801 | 3.51518 | 3.733 |
| 研究与开发 | 7.27074 | 5.26706 | 7.2909 | 6.5553 | 7.02607 |
| 营业收入 | -5.05223 | -3.96583 | -7.01933 | -9.27997 | -9.91363 |
| 利息收入（费用），非经营净值 | 0.08465 | 0.10941 | 0.09975 | 0.03579 | 0.00312 |
| 税前净收入 | -4.96758 | -3.85642 | -6.91958 | -9.24419 | -9.91051 |
| 税后净收入 | -4.96758 | -3.85642 | -6.91958 | -9.24419 | -9.91051 |
| 未计算非常项目前的净收益 | -4.96758 | -3.85642 | -6.91958 | -9.24419 | -9.91051 |
| 净收入 | -4.96758 | -3.85642 | -6.91958 | -9.24419 | -9.91051 |
| 普通股股东可获收益 (不含非经常性项目) | -4.96758 | -3.85642 | -6.91958 | -9.24419 | -9.91051 |
| 普通股股东可获收益 (含非經常性項目) | -4.96758 | -3.85642 | -6.91958 | -9.24419 | -9.91051 |
| 摊薄净收入 | -4.96758 | -3.85642 | -6.91958 | -9.24419 | -9.91051 |
| 摊薄后加权平均股 | 8.72103 | 8.37358 | 8.35992 | 8.3592 | 8.31076 |
| 扣除特别项目的每股摊薄盈利 | -0.56961 | -0.46055 | -0.82771 | -1.10587 | -1.19249 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| 每股正常摊薄盈利 | -0.56961 | -0.44692 | -0.82771 | -1.10587 | -1.17819 |
| 收入 | 4.73434 | 3.30914 | 3.94957 | 0.79051 | 0.96432 |
| 异常费用（收入） | 0 | 0.11409 | 0 | 0 | 0.11888 |
- 年度
- 每季度
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| 流动资产总额 | 16.6193 | 45.9822 | 24.4109 | 45.4866 | 61.9966 |
| 现金和短期投资 | 11.7822 | 42.3512 | 21.3524 | 43.9039 | 61.7467 |
| 现金等价物 | 11.7822 | 42.3512 | 21.3524 | 43.9039 | 61.7467 |
| Prepaid Expenses | 2.43508 | 2.48463 | 2.05792 | 1.52644 | 0.14172 |
| Total Assets | 34.4222 | 68.1351 | 45.6148 | 46.3593 | 62.1443 |
| Total Current Liabilities | 7.78181 | 12.9016 | 6.4018 | 1.99281 | 2.80357 |
| Payable/Accrued | 0.75561 | 3.04191 | 0.40401 | 0.44168 | 0.71957 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 2.5 | 1.14619 | 0 | 0.031 | 0.049 |
| Total Liabilities | 14.8211 | 24.1495 | 18.2702 | 2.27306 | 2.80357 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 19.601 | 43.9856 | 27.3446 | 44.0862 | 59.3407 |
| Preferred Stock - Non Redeemable, Net | |||||
| Common Stock | 0.00841 | 0.08308 | 0.05073 | 0.04573 | 0.04544 |
| Additional Paid-In Capital | 447.642 | 442.021 | 383.533 | 371.574 | 365.401 |
| Retained Earnings (Accumulated Deficit) | -428.049 | -398.118 | -356.239 | -327.533 | -306.105 |
| Total Liabilities & Shareholders’ Equity | 34.4222 | 68.1351 | 45.6148 | 46.3593 | 62.1443 |
| Total Common Shares Outstanding | 8.4 | 8.31 | 5.07 | 4.57 | 4.54 |
| 应收账款总额，净额 | 2.402 | 0.00024 | 1 | 0.05619 | 0.10818 |
| Property/Plant/Equipment, Total - Net | 17.8029 | 22.1529 | 21.204 | 0.8727 | 0.14767 |
| Property/Plant/Equipment, Total - Gross | 23.0768 | 24.8931 | 21.7952 | 0.97817 | 0.14767 |
| Accumulated Depreciation, Total | -5.27386 | -2.74014 | -0.59126 | -0.10547 | 0 |
| Accounts Payable | 1.612 | 5.144 | 2.935 | 0.993 | 1.619 |
| Accrued Expenses | 2.9142 | 3.56949 | 3.06279 | 0.52713 | 0.416 |
| Other Liabilities, Total | 7.03934 | 11.2479 | 11.8684 | 0.28025 | |
| Other Current Assets, Total | 0 | 1.14619 | 0.00056 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| 流动资产总额 | 10.9129 | 16.6193 | 22.4231 | 29.276 | 31.0175 |
| 现金和短期投资 | 6.40124 | 11.7822 | 18.0764 | 25.8217 | 28.6372 |
| 现金等价物 | 6.40124 | 11.7822 | 18.0764 | 25.8217 | 28.6372 |
| 应收账款总额，净额 | 2.08289 | 2.402 | 1.68102 | 0.62763 | 0.00219 |
| Prepaid Expenses | 2.42874 | 2.43508 | 2.66567 | 2.8267 | 2.19623 |
| Total Assets | 27.941 | 34.4222 | 41.1146 | 52.3197 | 54.9561 |
| Property/Plant/Equipment, Total - Net | 17.0282 | 17.8029 | 18.6915 | 23.0437 | 23.9386 |
| Property/Plant/Equipment, Total - Gross | 23.1203 | 23.0768 | 23.3627 | 26.9395 | 27.2547 |
| Accumulated Depreciation, Total | -6.09209 | -5.27386 | -4.67118 | -3.89584 | -3.31606 |
| Total Current Liabilities | 5.20405 | 7.78181 | 11.2868 | 13.4736 | 8.21451 |
| Accounts Payable | 2.863 | 1.612 | 2.021 | 1.767 | 5.016 |
| Payable/Accrued | 0.62397 | 0.75561 | 0.7174 | 0.66225 | 0.74068 |
| Accrued Expenses | 1.71708 | 2.9142 | 3.49845 | 3.04439 | 2.27597 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 12.0277 | 14.8211 | 18.5128 | 24.2935 | 19.2504 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities, Total | 6.82365 | 7.03934 | 7.22599 | 10.8198 | 11.0359 |
| Total Equity | 15.9134 | 19.601 | 22.6017 | 28.0263 | 35.7058 |
| Common Stock | 0.0088 | 0.00841 | 0.0836 | 0.0836 | 0.08345 |
| Additional Paid-In Capital | 448.921 | 447.642 | 446.711 | 445.216 | 443.651 |
| Retained Earnings (Accumulated Deficit) | -433.017 | -428.049 | -424.193 | -417.273 | -408.029 |
| Total Liabilities & Shareholders’ Equity | 27.941 | 34.4222 | 41.1146 | 52.3197 | 54.9561 |
| Total Common Shares Outstanding | 8.8 | 8.4 | 8.36 | 8.36 | 8.35 |
| Other Current Assets, Total | 0 | 0 | 0 | 0.18186 | |
| Other Current Liabilities, Total | 0 | 2.5 | 5.05 | 8 | 0.18186 |
| Accounts Receivable - Trade, Net | 1 |
- 年度
- 每季度
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| 净收入/起跑线 | -29.9307 | -41.8789 | -28.7061 | -21.428 | -147.958 |
| 经营活动产生的现金 | -26.9722 | -27.2798 | -20.0347 | -18.2843 | -14.4799 |
| 非现金物品 | 5.98266 | 6.9777 | 5.78745 | 5.52043 | 132.435 |
| Cash Taxes Paid | |||||
| 已付现金利息 | |||||
| 营运资金的变化 | -5.81323 | 5.47242 | 2.39829 | -2.48188 | 1.04252 |
| 融资活动产生的现金 | 0.20213 | 52.5559 | 6.73601 | 0.81648 | 71.245 |
| 融资现金流项目 | |||||
| 股票的发行（报废），净额 | 0.20213 | 52.5559 | 6.73601 | 0.81648 | 71.245 |
| 债务的发行（退还），净额 | |||||
| 现金净变化 | -31.7152 | 22.145 | -22.5516 | -17.8428 | 56.6175 |
| 投资活动产生的现金 | -4.94514 | -3.13113 | -9.25289 | -0.37498 | -0.14767 |
| 资本支出 | -4.94514 | -3.13113 | -9.25289 | -0.37498 | -0.14767 |
| 经营活动产生的现金 | 2.78911 | 2.14898 | 0.48564 | 0.10512 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -4.96758 | -29.9307 | -26.0743 | -19.1547 | -9.91051 |
| Cash From Operating Activities | -5.8883 | -26.9722 | -20.6667 | -13.0208 | -12.2261 |
| Cash From Operating Activities | 0.81822 | 2.78911 | 1.976 | 1.15611 | 0.57633 |
| Non-Cash Items | 0.81343 | 5.98266 | 5.11359 | 3.64886 | 1.88857 |
| Changes in Working Capital | -2.55237 | -5.81323 | -1.68204 | 1.32896 | -4.78045 |
| Cash From Investing Activities | -0.11261 | -4.94514 | -4.81779 | -4.71843 | -2.45219 |
| Capital Expenditures | -0.11261 | -4.94514 | -4.81779 | -4.71843 | -2.45219 |
| Cash From Financing Activities | 0.61997 | 0.20213 | 0.06357 | 0.06357 | 0 |
| Issuance (Retirement) of Stock, Net | 0.61997 | 0.20213 | 0.06357 | 0.06357 | 0 |
| Net Change in Cash | -5.38093 | -31.7152 | -25.4209 | -17.6756 | -14.6783 |
交易计算器
如果您在特定日期（选择一个日期）开立差价合约交易并在不同日期（选择一个日期）关闭交易，计算您的假设盈亏。
交易佣金
0
- 1:1
杠杆
1:1
- 20
- 100
- 500
- 1000
- 10000
投资
交易规模（杠杆 x 投资）：
開倉
平仓
做空 做多
Marker Therapeutics, Inc. Company profile
关于 Marker Therapeutics Inc.
Marker Therapeutics, Inc.是一家处于临床阶段的免疫肿瘤学公司。 该公司专门从事基于T细胞的免疫疗法和基于肽的疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体肿瘤的适应症。 公司从其MultiTAA特异性T细胞技术中开发出了领先的候选产品，该技术基于非工程化的肿瘤特异性T细胞的选择性扩增，这些T细胞能够识别肿瘤相关抗原（TAAs），这些抗原是肿瘤靶点，然后杀死表达这些靶点的肿瘤细胞。 该公司有三种MultiTAA特异性T细胞疗法通过临床开发，其中包括自体MultiTAA特异性T细胞疗法，异体MultiTAA特异性T细胞疗法和现成的MultiTAA特异性T细胞疗法。 公司专注于开发MT-601，用于治疗晚期不可切除的胰腺癌。
| Industry: | Biotechnology & Medical Research (NEC) |
4551 Kennedy Commerce Dr.
HOUSTON
TEXAS 77032
US
收入报表
- Annual
- Quarterly
人们也观看
还在找一位您可以信任的经纪商吗？
加入成为全球535,000万多名交易者的一份子，选择利用Capital.com进行交易吧。